“Monoclonal Antibody Therapy of T Cell Lymphoma: Single Agent Trials of Anti-CD2 (Siplizumab) and Anti-CD4 (Humax-CD4)”. Hematology Meeting Reports (formerly Haematologica Reports) 3, no. 1 (June 11, 2009). Accessed June 20, 2025. https://journals.pagepress.org/hmr/article/view/532.